PanLeucogating Akin Abayomi

Similar documents
ACS GUIDELINE FOR LYMPHOCYTE SUBSET IMMUNOPHENOTYPING. Second Edition Australasian Cytometry Society Guideline Document

Technical Bulletin No. 157

How can Blood Stabilizers be used for Validation of New Instruments? UK NEQAS for Leucocyte Immunophenotyping

PointCare NOW TM Technical Note

External validation for CD4 and viral load assays: South African Experience

Human Progenitor Cell Enumeration by Flow Cytometry Practical Considerations

WHO Prequalification of Diagnostics Programme PUBLIC REPORT

Application Note. Productivity and Efficiency of 6-Color BD Multitest and BD Trucount Technologies for Enumeration of Lymphocyte Subsets

CELL-DYN Strength in Technology, Proven Reliability. Optical WBC Technology. Patented M.A.P.S.S. Differential. Multiple Technologies

BD Multitest IMK Kit

Getting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation.

B and T-Cells. CD8+ Cytotoxic T Cells

Application Information Bulletin: Navios Multi-center Study

Affordable CD4 -T-Cell Counting by Flow Cytometry: CD45 Gating for Volumetric Analysis

Tube 1 : FLAER/CD24/CD16/CD15/CD45

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Evaluation of a Method for Counting Absolute Numbers of Cells with a Flow Cytometer

DEFINITIVE ANNUAL REPORT FLOW CYTOMETRY: LYMPHOCYTE SUBSET ANALYSIS CD34+ STEM CELL ENUMERATION 2013

DEFINITIVE ANNUAL REPORT FLOW CYTOMETRY: LYMPHOCYTE SUBSET ANALYSIS CD34+ STEM CELL ENUMERATION 2014

DEFINITIVE ANNUAL REPORT FLOW CYTOMETRY: LYMPHOCYTE SUBSET ANALYSIS CD34+ STEM CELL ENUMERATION 2015

Establishing a Pure Lymphocyte Gate for Subset Analysis by Flow Cytometry

The properties of CD45/ SS in the blast Population of AML Sudanese patients

CELL-DYN 3700 Strength in Technology, Proven Reliability

CPAL and GenPath Flow Cytometry Specimen Handling

CyFlow SL_3. Healthcare Immunology. Portable FCM System for Routine HIV/AIDS Monitoring of Adult and Pediatric Patients

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

Update on CD4+ T-Cell Counting Technologies

WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Pima CD4 Test Number: PQDx Abstract

Flow Cytometric Analysis of T -Lym phocytes Subsets in Adult Thais

BD Simultest IMK Plus

The Immune System. A macrophage. ! Functions of the Immune System. ! Types of Immune Responses. ! Organization of the Immune System

Flow cytometry leukocyte differential : a critical appraisal

Original Article Time and temperature stability of T-cell subsets evaluated by a dual-platform method

Dynamic analysis of lymphocyte subsets of peripheral blood in patients with acute self-limited hepatitis B

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Meet the HemoCue WBC DIFF

Flow cytometric CD4 enumeration of four different HIV-Infected blood samples at the cost of one monoclonal antibody reagent

Monocyte subsets in health and disease. Marion Frankenberger

Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007

Chemotherapy Effect on Neutrophils Function in Leukemic Patients

Evaluation of the Abbott CELL-DYN 4000 Hematology Analyzer

BD Flow Cytometry Reagents Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-20 Cell Analyzer

HumaCount 5D. Outperforming 5-part Hematology System. CoreLab DX. Hematology

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

Leukocytosis - Some Learning Points

Test Utilization: Chronic Lymphocytic Leukemia

Guidelines for HIV Rapid Test Kits Evaluation

a Beckman Coulter Life Sciences: White Paper

DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS

Effects of Meditation on the T-lymphocytes, B-lymphocytes and Natural Killer Cells Production

Evaluation of a Single-Platform Technology for Lymphocyte Immunophenotyping

4. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5 TH EDITION. Chapter 2. pg

Complete Blood Count (CBC) Assist.Prof. Filiz BAKAR ATEŞ

21 st Century Cures Initiative

Understanding Poor Vaccine Responses: Transcriptomics of Vaccine Failure

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, May 2000, p Vol. 7, No. 3

Phagocytosis of FITC labelled opsonized and non-opsonized E. coli bacteria by monocytes and granulocytes in a whole blood assay

Performance evaluation of Celltac G: a new automated hematology analyzer

Animal tissue-specific biomolecules influence on rats with cyclophosphamide-induced immunosuppression

ISCT Workshop #7 Perspectives in Cell Selection Immunomagnetic Selection

Technical Brief on CD4 Technologies (May 2010)

Myelodysplastic scoring system with flow cytometry. G Detry B Husson

Supplementary Figure 1

Anti-Infective Clinical Trials

Successful flow cytometric immunophenotyping of body fluid specimens

Evaluation of a CD4-aptamer for Flow Cytometry-based Enumeration of T-cell Subsets

Evaluation of the Diagnostic Performance of the Sysmex XT-2000i Automated Hematology Analyzer in the Detection of Immature Granulocytes

Care and Treatment of Children and Adolescents with HIV - The Barbados Experience.

Received 6 November 2006/Returned for modification 4 January 2007/Accepted 9 January 2007

The spectrum of flow cytometry of the bone marrow

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Melanoma Bridge Meeting

Test Bulletin. Save time, money, resources, and precious blood by NOT collecting extra specimens just in case

Blood consists of red and white blood cells suspended in plasma Blood is about 55% plasma and 45% cellular elements Plasma 90% water 10% dissolved

PEPFAR and Treatment 2.0

SUPPLEMENTARY INFORMATION In format provided by Stevens et al. (NOVEMBER 2008)

Professor of Medicine, Johns Hopkins Bloomberg School of Public Health; Director, Johns Hopkins Center for Global Health, Baltimore, MD

Unit title: The Immune Response System

Current Laboratory Practices in Flow Cytometry for the Enumeration of CD4 + T-Lymphocyte. Subsets

ADVANCED HAEMATOLOGY BATTLE OF THE BANDS. Dennis B. DeNicola, DVM, PhD, DACVP IDEXX Laboratories, Inc. Westbrook, Maine, USA BACKGROUND

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit

Quality Management 333 Liam Whitby 1.2 Liam Whitby 24-Jul Jul-2016 unknown

NASSAU BAHAMAS AUGUST 25 TH - 29 TH Highlights 2013

Immunological and hematological reference values for apparently healthy HIV-negative adults in Bahir Dar Town, Ethiopia

HIV in the Haematology laboratory in South Africa: Challenges and Poten<al Solu<ons

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah

Guide to the 1-3 Minute Blood Film Microscopic Review: Why and How?

Determination of monocyte count by hematological analyzers, manual method and flow cytometry in polish population

Flow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma

WHITE PAPER IMMATURE GRANULOCYTE (IG) POPULATIONS MAY IMPROVE THE ASSESSMENT OF INFECTION AND SEPSIS. Getting beyond the flags.

Grant Summary Report: Expansion of Nucleic Acid Amplification Testing for TB In Public Health Laboratories

CyFlow Counter. The Complete Solution for HIV/AIDS Monitoring. Essential Healthcare. HIV/AIDS Monitoring Patient Follow-up

Bone marrow transplantation for PID

Composition of Blood

Received 21 January 2007/Returned for modification 1 March 2007/Accepted 22 March 2007

Customer Information Literature List White Blood Cells

BD Simultest CD3/CD16+CD56

Transcription:

PanLeucogating Akin Abayomi Cost effective CD4 counting at a central laboratory. The Barbados experience. CCAS Surinam 2008

Appreciation Frank Mandy George Janossy Phil McCoy John Codrington Clive Landis CCAS executive and faculty Fellow colleagues Sponsors and Vendors People of Surinam for hosting us

How can you heal me if you don t like me George Barron It is recorded in history that Jesus had compassion on the multitude and many were healed. We need a global community of health care providers who are infused with compassion.

CARIBBEAN HIV WORKSHOP 1 ST CARIBBEAN HIV WORKSHOP 2004

Caribbean Water fall calculation Prevalence of 3% in the Caribbean popu of ~40Million 230,000 found with HIV?? 50,000 need ARVs

How to identify the 230,000 Need to engage mass VCT programs VCT wont be attractive without capacity to: Stage patients @ presentation Monitor with CD4 Offer ARVs and other OIP Post ARV Monitoring (CD4/VL/CD38) In other words comprehensive care

HIV Infection is characterized by a steady decline in the number of CD4 cells Acute Infection Asymptomatic HIV Infection AIDS CD4 Cell Count 1,000 500 200 CD4 Cells 4-8 Weeks Up to 12 Years 2-3 Years

Protocols: Predicate vs Sustainable Two tubes, 4 colours each Several levels of quality High purity and high recovery Expensive Current guidelines One tube, two or even one colour Cheap Questionable accuracy

Annual cost be to Caricom to measure three CD4 s per year [Predicate method] 230,000 @ 25USD = $17 million

basophils lymphocytes monocytes platelets eosinophils erythrocytes neutrophils

Side Scatter Granulocytes Basophils Eosiniphils Neutrophils Monocytes Lymphocytes

Lymphocyte Subsets Total Lymphocytes T Lymphocytes (CD3+CD4+) T Lymphocytes B Lymphocytes NK Cells NK Cells CD56+CD16+CD3- + + CD3+CD8+ T Cytotoxic B Lymphocytes CD19+ +

What is flowcytometry?

Some basic definitions Gating Homogenous vs Heterogenous Dual vs single platform (beads or Volumetric) Purity and recovery Primary gating

Side Scatter Granulocytes Basophils Eosiniphils Neutrophils Monocytes Lymphocytes

FLUORESCENCE vs SIDE SCATTER B Cells Monocytes T-Cells

The recovery of the gate is the percentage of cells of interest in the sample that are within the gate. Cells may fall outside the gate.

The purity of the gate is the percentage of cells within the gate that are the cells of interest. There may be contaminants.

Side Scatter Granulocytes Basophils Eosiniphils Neutrophils Monocytes Lymphocytes

Lymphocyte Subsets Total Lymphocytes T Lymphocytes (CD3+CD4+) T Lymphocytes B Lymphocytes NK Cells NK Cells CD56+CD16+CD3- + + CD3+CD8+ T Cytotoxic B Lymphocytes CD19+ CD3- +

WHAT ENVIRONMENT ARE YOU WORKING IN? WHAT IS APPROPRIATE TECHNOLOGY FOR YOUR LOCATION?

WHO suggest use TLC Use of Total Lymphocyte Count derived from a haematology cell counter. If TLC is < 1,200 then suggests CD4 is also in the region of 200 or below. We looked at that also

Results Figure 1: Scatter of Absolute CD4 count and lymphocyte count Cd4am=M Cd4af=F

Results The regression equation is: ŷ = 132 + 231(lym1) + 419(lym2) 86(sex) Where ŷ is derived mean of predicted CD4 lym1=1, for lymphocyte count 1000-2000, 0 otherwise lym2 =1 for lymphocyte count >2000; 0 otherwise sex = 0 : female, 1 : male

TLC Machine C 7000 6000 5000 4000 3000 2000 1000 0 0 1000 2000 3000 4000 5000 Lymphosum r 2 =0.8705

TLC Machine B 6000 5000 r 2 =0.02477 4000 3000 2000 1000 0 0 1000 2000 3000 4000 5000 Lymphosum

Findings! Initial findings suggests that absolute CD4 counts can be predicted by lymphocyte counts provided!!!!! These findings support the algorithm provided by the WHO Which suggest that a TLC of 1200 /µl may be suggestive of a CD4 of 200 Cells /µl

HIV CAUSES 2 TYPES OF AIDS THE ONE WE ARE MORE FAMILIAR WITH IS THE ADULT ACQUIRED IMMUNE DEFICIENCY SYNDROME

HIV HAS ACCELERATED THE ADVANCEMENT IN CAPACITY FOR: INFRASTRUCURE DIAGNOSTICS AND SPECIALIST SERVICES

A central referral health care facility Should be able to provide flow for More than just CD4 counting Leukaemia lymphoma Fine needle aspiration Infectious disease Immunological assays Research Forensics

So at QEH and in Barbados we opted for an open 4 colour system with a long term vision for sustainability and service to the medical community at large.

Principle of Cell Counting by Flow Cytometry Laser Flow Cuvette Fluorescence Emission,, ^^^^^^^^^^^^^^^^^^^^ ^^^^^^^^^^^^^^^^^^^^ ^^^^^^^^^^^^^^^^^^^^ PMT

High Purity Rolls Royce CD4 The Principle High Recovery

The lymphocyte recovery of the gate is the percentage of lymphocytes in the sample that are within the gate. The lymphocyte purity of the gate is the percentage of cells within the gate that are lymphocytes. The remainder may be monocytes, granulocytes, red cells, platelets, and debris.

Percentage lymphocyte recovery cannot be determined without using a panel of monoclonal antibodies that identify T-, B-, and NK-cells.

Addition of CD45 to a single tube containing CD3,CD4, and CD8 allows the identification of lymphocytes based on CD45 and side scatter and the enumeration of CD4+ and CD8+ T- lymphocytes. CD19+ B-cell values may be essential for assessing the immune status of pediatric patients. Use of a second tube containing a natural killer (NK) cell marker together with CD3 and CD19 can help to assess the recovery and purity of the lymphocytes within the CD45/side-scatter gate.

TETRA PANEL CD45/CD4/CD8/CD3 First Tube CD45 Gating Monos exclusion Refine with CD3- CD4+

CD3+ CD8+ CD3

TETRA PANEL CD45/CD56/CD19/CD3 Second tube CD3-CD56+

CD3-CD19+ CD3+ CD3+CD56+CD19=TLC

General consensus is that: Results obtained from Rolls Royce protocols are not more accurate than a simple Primary CD4 gating even in ageing samples Janossy, G., Jani, I., Göhde, W., BJH, 2000, Vol. 111 Bergeron M., Mandy F. Cytometry, 2002, 50 Denny T. Cytometry part B, 2008, 74B

PLG in Barbados Sippy-Chatrani N, Marshall S, Branch S, Carmichael- Simmons K, Clive Landis R, Abayomi A. Performance of the Panleucogating Protocol for CD4+ T Cell Enumeration in an HIV Dedicated Laboratory Facility in Barbados.

PLG? Originally designed for dual platform And capacity to analyse old samples Converted to Single platform Made Pan Leucogate redundant Essentially now prim CD4 gating protocol Can do % for paediatrics if required

A synopsis 150 blood samples analyzed Good correlation between two protocols in the clinically relevant range Bland Altman showed good agreement Cost analysis has actually showed a saving of USD 17.86 per test for reagents

A B C Panleugogate Lymphocyte gate CD4 + Lymphocytes Figure 1: (A) A panleucogate is drawn using CD45 and side scatter fluorescence to identify all white cells. (B) Events in the panleucogate staining CD4 positive show a clear separation between CD4 positive and negative cells. (C) Percentage of CD4 positive cells in the lymphocyte gate. This sample has a CD4 count of 154 cells/µl and CD4 % of 10.4.

a) b) c) CD4 count = 608 cells/µl ; CD4 % = 45.6

a) b) c) CD4 count = 620 cells/µl ; CD4 % = 20.3

a) b) c) CD4 count = 431 cells/µl ; CD4 % = 17.2

a) b) c) CD4 count = 475 cells/µl ; CD4 % = 27.2

Absolute counts - PLG protocol Comparison of the Panleucogating technique with fourcolour heterogenous gating for enumeration of CD4 + T cell counts by flowcytometry Excellent correlation observed between absolute counts obtained using PLG & TetraONE system. 1250 1000 750 500 250 Absolute counts obtained with Panleucogating in Single platform & Dual platform settings R 2 = 0.97 R 2 = 0.96 0 0 250 500 750 1000 Absolute counts Four- colour protocol Single Platform Dual Platform

Difference (CD4 cells/ l TetraOne vs. PLG) Dual Comparison Bland-Altman analysis comparing TetraOne vs. PLG single and dual platforms Single 100 75 50 25 0-25 -50-75 -100 + 2 S.D. Bias: +4.60 cells/ l - 2 S.D. 250 500 750 1000 Absolute CD4 counts (cells/ l)

Acceptable CD4? Co morbidity, TB, Hepatitis, HTLV,Malaria, Gastritis, lymphomas Error in CD4 purity = Error in CD4 recovery

Cost Implication for CD4 analysis TEST COST PLG + Ancillary Quality Control reagents Annual budget after 2006 Four colour monoclonal antibody + Ancillary Quality Control reagents Annual budget prior to 2006 US$ 8.00 US$ 52,000 US$ 25.86 US$ 119,000

Annual cost be to Caricom to measure three CD4 s per year. Predicate vs Alternative 230,000 @ 25USD = $17 million 230,000 @ 8USD = $ 5.5 million 230,000 @ 2USD = $1.4 million *

THE NEXT BOLT?